SPAG1 Gene Primary Ciliary Dyskinesia Type 28 NGS Genetic DNA Test
Comprehensive Genetic Analysis for Respiratory Health
The SPAG1 Gene Primary Ciliary Dyskinesia Type 28 NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for chronic respiratory conditions. This advanced test specifically targets mutations in the SPAG1 gene, which plays a crucial role in the proper functioning of cilia – microscopic hair-like structures that line the respiratory tract and other organs. When these cilia malfunction due to genetic mutations, it leads to Primary Ciliary Dyskinesia (PCD), a rare inherited disorder affecting multiple body systems.
What Does This Test Measure?
Our state-of-the-art NGS Genetic DNA Test provides comprehensive analysis of the SPAG1 gene to identify:
- Point mutations and single nucleotide variations
- Insertions and deletions affecting gene function
- Copy number variations and structural changes
- Pathogenic variants associated with PCD Type 28
- Carrier status for family planning purposes
Who Should Consider This Test?
This genetic test is recommended for individuals experiencing:
- Chronic respiratory infections from early childhood
- Persistent nasal congestion and sinusitis
- Recurrent middle ear infections and hearing loss
- Chronic cough with sputum production
- Bronchiectasis or abnormal lung function
- Infertility issues or situs inversus (organ reversal)
- Family history of Primary Ciliary Dyskinesia
Clinical Benefits of Genetic Testing
Undergoing the SPAG1 Gene PCD Type 28 test provides numerous advantages:
- Accurate Diagnosis: Confirms or rules out PCD Type 28 with high precision
- Personalized Treatment: Enables targeted management strategies
- Family Planning: Provides crucial information for genetic counseling
- Early Intervention: Allows proactive management of symptoms
- Comprehensive Care: Facilitates multidisciplinary approach involving ENT specialists and geneticists
Understanding Your Test Results
Our comprehensive genetic report includes:
- Detailed analysis of SPAG1 gene variants
- Clinical significance interpretation by certified geneticists
- Recommendations for further evaluation if needed
- Genetic counseling guidance for positive results
- Family testing recommendations
Positive results indicate the presence of pathogenic mutations associated with PCD Type 28, while negative results significantly reduce the likelihood of this specific genetic condition. All results are reviewed by our team of genetic specialists to ensure accurate interpretation.
Test Pricing and Details
| Test Feature | Details |
|---|---|
| Test Name | SPAG1 Gene Primary Ciliary Dyskinesia Type 28 NGS Genetic DNA Test |
| Discount Price | $500 USD |
| Regular Price | $700 USD |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type | Blood, Extracted DNA, or One Drop Blood on FTA Card |
| Testing Method | Next-Generation Sequencing (NGS) Technology |
Nationwide Testing Availability
We have conveniently located branches across the United States, serving patients in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified genetic testing facilities ensures accessible, reliable testing for patients nationwide.
Take Control of Your Respiratory Health Today
Don’t let chronic respiratory symptoms control your life. The SPAG1 Gene Primary Ciliary Dyskinesia Type 28 NGS Genetic DNA Test provides the clarity needed for proper diagnosis and management. Our team of genetic specialists and ENT doctors are ready to help you understand your genetic profile and develop an effective treatment plan.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic test consultation and take the first step toward better respiratory health management.
